Cargando…
Hepatitis C Virus Evasion from RIG-I-Dependent Hepatic Innate Immunity
Exposure to hepatitis C virus (HCV) usually results in persistent infection that often develops into chronic liver disease. Interferon-alpha (IFN) treatment comprises the foundation of current approved therapy for chronic HCV infection but is limited in overall efficacy. IFN is a major effector of i...
Autores principales: | Liu, Helene Minyi, Gale, Michael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026989/ https://www.ncbi.nlm.nih.gov/pubmed/21274284 http://dx.doi.org/10.1155/2010/548390 |
Ejemplares similares
-
Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition
por: Zhou, Li, et al.
Publicado: (2021) -
Host Innate Immunity Against Hepatitis Viruses and Viral Immune Evasion
por: Xu, Chonghui, et al.
Publicado: (2021) -
Emerging complexity and new roles for the RIG-I-like receptors in innate antiviral immunity
por: Errett, John S., et al.
Publicado: (2015) -
RIG-I in RNA virus recognition
por: Kell, Alison M., et al.
Publicado: (2015) -
Suppression of hepatitis B virus through therapeutic activation of RIG-I and IRF3 signaling in hepatocytes
por: Lee, Sooyoung, et al.
Publicado: (2021)